P3 Health Partners Inc reports results for the quarter ended March 31 - Earnings Summary
15/05/2025 22:00
P3 Health Partners Inc PIII.OQ reported a quarterly adjusted loss of $6.28 per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of $-8.00. The mean expectation of five analysts for the quarter was for a loss of $8.91 per share. Wall Street expected results to range from $-13.00 to $-5.50 per share. Revenue fell 3.9% to $373.23 million from a year ago; analysts expected $358.35 million. P3 Health Partners Inc's reported EPS for the quarter was a loss of $6.28. The company reported a quarterly loss of $20.48 million. P3 Health Partners Inc shares had fallen by 0.3% this quarter and lost 27.3% so far this year. FORECAST CHANGES The mean earnings estimate of analysts had fallen by about 40.8% in the last three months. In the last 30 days, one analyst negatively revised an earnings estimate RECOMMENDATIONS The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy" Wall Street's median 12-month price target for P3 Health Partners Inc is $20.00 This summary was machine generated from LSEG data May 15 at 09:00 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
| QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
| Mar. 31 2025 | -8.91 | -6.28 | Beat |
| Dec. 31 2024 | -4.10 | -19.50 | Missed |
| Sep. 30 2024 | -1.87 | -14.50 | Missed |
| Jun. 30 2024 | -2.50 | -4.50 | Missed |
Recent news on P3 Health Partners
See all newsBrief: P3 Health Partners Entered SPA With Affiliates Of CPF Pursuant To Which To Issue Up To $70 Million Of Units In Multiple Tranches - SEC Filing
P3 Health Partners Inc reports results for the quarter ended June 30 - Earnings Summary
P3 Health Partners lifts 2026 adjusted EBITDA outlook amid structural improvements
P3 Health Partners Inc expected to post a loss of $1.89 a share - Earnings Preview
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:55 AM